(Q34667065)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044925%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

review article

1 reference

title

Hyperandrogenaemia and the ovary (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044925%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044925%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

Robert J Norman

1 reference

3 August 2017

1 May 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044925%20AND%20SRC:MED&resulttype=core&format=json

Molecular and Cellular Endocrinology

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044925%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

191

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044925%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044925%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

113-119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044925%20AND%20SRC:MED&resulttype=core&format=json

Insights into the development of polycystic ovary syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys.

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

The potential role of intraovarian factors on ovarian androgen production.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Fetal growth, length of gestation, and polycystic ovaries in adult life

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Insulin sensitizers and antiandrogens in the treatment of polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Insulin resistance in polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Laparoscopic treatment of polycystic ovaries with insulated needle cautery: a reappraisal.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Peripheral and local regulators of folliculogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Internal carotid artery haemodynamics in women with polycystic ovaries.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

The genetics of obesity. Lessons for polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Diabetes prevalence and risk factors in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Preliminary investigation of follistatin gene mutations in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

The importance of diagnosing the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Local control of ovarian steroidogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Obesity, insulin, sex steroids and ovulation

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Cytokines in the ovary: pathophysiology and potential for pharmacological intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Mortality of women with polycystic ovary syndrome at long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Distribution of leukocyte subtypes in the sheep ovary after laser drilling

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Surgical management of polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

Differential activity of the cytochrome P450 17alpha-hydroxylase and steroidogenic acute regulatory protein gene promoters in normal and polycystic ovary syndrome theca cells

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2802%2900062-X

7 January 2021

10.1016/S0303-7207(02)00062-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12044925%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference